BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,032.38
      0.56%
      US Tech 100
      20,389.60
      0.88%
      Dow Jones
      44,910.65
      0.42%
      Brent Oil
      71.98
      0.00%
      Bitcoin
      96,664.50
      0.24%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Defence Therapeutics Inc (QB) (DTCFF) Quote

      Defence Therapeutics Inc (QB)

      Defence Therapeutics Inc (QB) (DTCFF)

      USOTC
      0.4093
      0.00
      (0.00%)
      Closed November 30 4:00PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.4093
      Bid
      0.0101
      Ask
      0.7351
      Volume
      -
      0.00 Day's Range 0.00
      0.40 52 Week Range 2.07
      Market Cap
      18.638M
      Previous Close
      0.4093
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,025
      Shares Outstanding
      45,536,673
      Dividend Yield
      -
      PE Ratio
      -1.42
      Earnings Per Share (EPS)
      -0.29
      Revenue
      -
      Net Profit
      -13.19M

      About Defence Therapeutics Inc (QB)

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.defencetherapeutics.com
      Headquarters
      Vancouver, British Columbia, Can
      Founded
      -
      Defence Therapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker DTCFF. The last closing price for Defence Therapeutics (QB) was $0.41. Over the last year, Defence Therapeutics (QB) shares have traded in a share price range of $ 0.40 to $ 2.07.

      Defence Therapeutics (QB) currently has 45,536,673 shares outstanding. The market capitalization of Defence Therapeutics (QB) is $18.64 million. Defence Therapeutics (QB) has a price to earnings ratio (PE ratio) of -1.42.

      Ask ADVFN Intelligence (AI)

      DTCFF Latest News

      More News

      DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER

       DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER  Vancouver, BC, Canada, February 16th, 2022 -- InvestorsHub NewsWire Defence Therapeutics Inc...

      February 16 2022
      InvestorsHub NewsWire

      Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9

        Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9   Vancouver, BC, Canada, January 26th...

      January 26 2022
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT

      Vancouver, BC, Canada -- November 30th 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. (CSE: DTC; FSE: DTC; USOTC: DTCFF) ("Defence" or the...

      November 30 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

      DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER   Vancouver, BC, Canada -- November 23, 2021 -- InvestorsHub NewsWire...

      November 23 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS

       DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS Vancouver, BC, Canada, November 9th, 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. CSE:DTC, USOTC:DTCFF...

      November 09 2021
      InvestorsHub NewsWire

      VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS

        VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS   Vancouver, BC, Canada, November...

      November 03 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER

        DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER   Vancouver, BC, Canada, October 13th...

      October 13 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA

          DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA Vancouver, BC, Canada, October 6th, 2021 -- InvestorsHub NewsWire -- Defence...

      October 06 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER

       DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER Vancouver, BC, Canada, September 29th, 2021 - InvestorsHub NewsWire -- Defence Therapeutics Inc...

      September 29 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS

       DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS Vancouver, BC, Canada, September 20th, 2021 -- InvestorsHub NewsWire -- Defence...

      September 20 2021
      InvestorsHub NewsWire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40.004581.131646570470.404720.40930.404729670.40799517CS
      120.00932.3250.40.46970.410250.4320207CS
      26-0.4025-49.581177630.81180.83460.410910.58210147CS
      52-1.6607-80.22705314012.072.070.48910.96551585CS
      156-3.9021-90.50656399314.31144.50160.410782.02582328CS
      260-2.0907-83.6282.56.40780.411902.81833651CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      EVOLSymbolic Logic Inc (CE)
      $ 0.99
      (98,999,900.00%)
      		600
      CRMBQCrumbs Bake Shop Inc (CE)
      $ 0.012
      (1,199,900.00%)
      		15.64k
      GPDBGreen PolkaDot Box Incorporated (CE)
      $ 0.0002
      (19,900.00%)
      		21.54k
      FCGDFirst Colombia Gold Corporation (PK)
      $ 0.0001
      (9,900.00%)
      		600k
      BIIOBionovate Technologies Corporation (CE)
      $ 0.0001
      (9,900.00%)
      		1.21k
      TIHETaihe Group Inc (CE)
      $ 0.000001
      (-100.00%)
      		1
      SBBGSeibels Bruce Group Inc (CE)
      $ 0.000001
      (-100.00%)
      		4
      MXLGFMX Gold Corporation (CE)
      $ 0.000001
      (-100.00%)
      		1.1k
      VIVEViveve Medical Inc (CE)
      $ 0.000001
      (-99.75%)
      		652
      SMGISMG Industries Inc (CE)
      $ 0.000001
      (-99.50%)
      		10k
      AITXArtificial Intelligence Technology Solutions Inc (PK)
      $ 0.00275
      (0.00%)
      		51.06M
      GTEHGenTech Holdings Inc (CE)
      $ 0.000001
      (0.00%)
      		48.25M
      HMBLHUMBL Inc (PK)
      $ 0.0002
      (-33.33%)
      		42.65M
      CBGLCannabis Global Inc (PK)
      $ 0.00015
      (50.00%)
      		41.81M
      GTVHGolden Triangle Ventures Inc (PK)
      $ 0.0008
      (33.33%)
      		41.61M

      DTCFF Discussion

      View Posts
      Man6677 Man6677 3 years ago
      Why are there no trades here ?

      Thank you !

      Great news today !
      👍️0
      newspopper newspopper 3 years ago
      Get in KITL .08-.10 news will be poppin
      👍️0
      newspopper newspopper 3 years ago
      Need more volume for Poppin action
      👍️0
      newspopper newspopper 3 years ago
      Looking for FDA Poppin news
      👍️0
      newspopper newspopper 3 years ago
      KITL news going to be poppin
      👍️0
      GOLDBUFFALO GOLDBUFFALO 3 years ago
      Seems to be a very interesting stock.
      👍️0

      Your Recent History

      USOTC
      DTCFF
      Defence Therapeutics (QB)
      Delayed Upgrade Clock